Vir Biotechnology (VIR) Change in Account Payables (2018 - 2026)
Vir Biotechnology (VIR) reported Change in Account Payables of -$4.2 million for Q1 2026, down 198.66% on a YoY basis from $4.3 million in Q1 2025, and down 243.01% sequentially from $3.0 million in Q4 2025.
Vir Biotechnology (VIR) Change in Account Payables (2018 - 2026) Analysis & Trends
Vir Biotechnology (VIR) has 9 years of Change in Account Payables data on file, last reported at -$4.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 198.66% year-over-year to -$4.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (up 169.66% YoY), and the FY2025 full-year result was $5.0 million, up 605.77% from the prior year.
- Change in Account Payables slipped to -$4.2 million in Q1 2026, from $3.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $8.9 million in Q2 2025 to a low of -$7.5 million in Q3 2023.
- A 5-year average of $77176.5 and a median of -$934000.0 in 2023 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 406.22% in 2025, while the deepest fall reached 292.52% in 2025.
- Tracing VIR's Change in Account Payables over 5 years: stood at $2.8 million in 2022, then fell by 6.18% to $2.6 million in 2023, then sank by 173.7% to -$1.9 million in 2024, then jumped by 252.63% to $3.0 million in 2025, then slumped by 243.01% to -$4.2 million in 2026.
- Business Quant data shows VIR's Change in Account Payables at -$4.2 million in Q1 2026, $3.0 million in Q4 2025, and -$5.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - | -4.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.23 Mn |
| Mar 31, 2026 | -4.23 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | -5.40 Mn |
| Sep 30, 2025 | -5.40 Mn |
| Jun 30, 2025 | 8.86 Mn |
| Jun 30, 2025 | 8.86 Mn |
| Mar 31, 2025 | -1.42 Mn |
| Mar 31, 2025 | -1.42 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Sep 30, 2024 | 3.11 Mn |
| Sep 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | -2.89 Mn |
| Jun 30, 2024 | -2.89 Mn |
| Mar 31, 2024 | 735,000.00 |
| Mar 31, 2024 | 735,000.00 |
| Dec 31, 2023 | 2.63 Mn |
| Dec 31, 2023 | 2.63 Mn |